Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

altRX vs Trinity Meds

altRX and Trinity Meds both sell semaglutide and tirzepatide; this is how their prices, coverage and records differ.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
altRX logo

altRX

6.7
★★★☆☆3.4/5

Best for: semaglutide from $1149/month

Visit altRX →
VS
Trinity Meds logo

Trinity Meds

7.5
★★★★☆3.8/5

Best for: compounded semaglutide at $149/month

Visit Trinity Meds →

If you are choosing between altRX and Trinity Meds, price alone will not settle it. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Trinity Meds leads our six-part score, 7.5 to 6.7. One of the two has an FDA warning letter on record, covered below.

altRX vs Trinity Meds price

altRX and Trinity Meds start at the same figure, $149 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.

Drug by drug: Semaglutide costs the same at both, $149 a month; tirzepatide is cheaper at Trinity Meds ($199 a month vs $249 a month).

Medications and formats

Both sell semaglutide and tirzepatide.

On format, altRX prices compounded injections and brand-name pens, while Trinity Meds prices compounded injections.

If you want the FDA-approved brand rather than a compounded version, altRX is the only one of the two with a brand-name price.

Where each one treats patients

Neither altRX nor Trinity Meds publishes the states it serves, so enter your state at the very start of each sign-up.

Pricing

altRX

Compounded GLP-1 (semaglutide) starting tierCompounded
$149/mo
semaglutide
Compounded GLP-1/GIP (tirzepatide) starting tierCompounded
$249/mo
tirzepatide
Brand-name Ozempic®Brand-name
$1149/mo
semaglutide
Brand-name Mounjaro®Brand-name
$1249/mo
tirzepatide
Brand-name Zepbound®Brand-name
$1249/mo
tirzepatide
Brand-name Wegovy®Brand-name
$1579/mo
semaglutide

Trinity Meds

Injectablecompounded injection
$149/mo
semaglutide

All-inclusive flat rate, same price every dose; as low as $129/mo on the 6-month plan

Injectablecompounded injection
$199/mo
tirzepatide

All-inclusive flat rate (reg $299); as low as $149/mo on the 12-month plan

What each price covers

Both prices cover the clinician visit, the medication itself and shipping.

altRX is silent on lab work and coaching.

Trinity Meds is silent on lab work and coaching.

altRX

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Trinity Meds

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Where each one scores higher

Overall, Trinity Meds scores 7.5 and altRX 6.7 out of 10.

Trinity Meds is stronger on value (6.6 vs 5.0) and trust & safety (6.5 vs 3.5).

Effectiveness, user experience, accessibility and support are within half a point.

How we score

altRX

6.7/10

Overall

Trinity Meds

7.5/10

Value25%

5.0A
vs
B
6.6

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

3.5A
vs
B
6.5

Accessibility10%

5.0A
vs
B
5.0

Support10%

7.0A
vs
B
7.0

FDA warning letters

The FDA sent altRX a warning letter dated June 8, 2026 (letter 728236), and it is still open.

Trinity Meds has no FDA warning letter on record with us.

Features & Coverage

FeaturealtRXTrinity Meds
Starting Price$149/mo$149/mo
Features✓8 features6 features
States AvailableNot disclosedNot disclosed
Compounded✓ Yes—
Brand Name✓ Yes—
FSA/HSA Accepted—✓ Yes
FDA Warning Letters1 letter✓None

About altRX

Compounded plans open at $149 for semaglutide and $249 for tirzepatide. Branded medication runs $1,149-$1,579, a figure that already contains the consult and the shipping. Every one of the four FDA-approved brands is stocked, Mounjaro, Ozempic, Wegovy and Zepbound, which no other entry in our directory matches. altRX works in both modalities, holds LegitScript certification, and prints the FDA compounded-medication disclaimer.

Read our full altRX review →

About Trinity Meds

Trinity Meds charges an all-inclusive flat rate of $149/month for compounded semaglutide and $199/month for tirzepatide, the same price at every dose, with free shipping and no insurance; multi-month plans drop the price further. The program is aimed at military women, spouses and veterans. You take a short online assessment and a CareValidate Health clinician reviews eligibility and prescribes if appropriate. The named entity is Trinity Meds Inc, but it publishes no terms page, names no pharmacies, and lists no states.

Read our full Trinity Meds review →

Pros & Cons

altRX

What we like

  • Tirzepatide costs $1249 a month, close to the $1249 median for brand-name tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication, clinician visits and shipping

Watch-outs

  • Semaglutide costs $1149 a month, 16% above the $990 median for brand-name semaglutide across the sellers we compare
  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • The FDA has issued altRX a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Trinity Meds

What we like

  • Semaglutide costs $149 a month, 19% below the $184 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $199 a month, 20% below the $250 median for compounded tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication, clinician visits and shipping
  • We found no FDA warning letters issued to Trinity Meds

Watch-outs

  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Trinity Meds

Trinity Meds wins this one, 7.5 to 6.7, above all for compounded semaglutide at $149/month. altRX fits better if semaglutide from $1149/month is your priority.

Choose altRX if…

You want semaglutide from $1149/month and an opening price near $149 a month.

Choose Trinity Meds if…

You want compounded semaglutide at $149/month and an opening price near $149 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

6.5

Sesame Care

Oral orforglipron alongside the injectables

8.4

Collective

Flat any-dose pricing, if you can absorb a $199 annual membership on top

8.6

Found

Tirzepatide at $169/month, 37% below the typical price

altRX vs Trinity Meds: FAQ

Neither on the entry price: altRX and Trinity Meds both start at about $149 a month. The difference is in what the price includes.
Yes, both sell semaglutide and tirzepatide.
altRX does not publish where it ships; Trinity Meds does not publish where it ships. Confirm your state before paying.
Both include the clinician visit, the medication itself and shipping.
altRX has an open FDA warning letter from June 8, 2026. Trinity Meds has none.
No. Neither altRX nor Trinity Meds pays us anything.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.